Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Rouse

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2000
Ciprofloxacin inhibition of experimental fracture healingP M Huddleston, J M Steckelberg, A D Hanssen, et al.
Journal of Clinical Microbiology|November 4, 2000
Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experienceR Patel, K E Piper, M S Rouse, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditisM S Rouse, J M Steckelberg, C M Brandt, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditisC M Brandt, M S Rouse, B M Tallan, et al.
The Journal of Infectious Diseases|April 1, 1996
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agentsC M Brandt, M S Rouse, N W Laue, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococciW C Hellinger, M S Rouse, P M Rabadan, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditisJ M Steckelberg, M S Rouse, B M Tallan, et al.
The Journal of Infectious Diseases|December 23, 1999
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitisR Patel, M S Rouse, M V Florez, et al.
Tissue Antigens|December 19, 2007
Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic miceG Rajagopalan, G Polich, M M Sen, et al.
Journal of Clinical Microbiology|October 17, 1998
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolatesR Patel, K E Piper, M S Rouse, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2000
Ciprofloxacin inhibition of experimental fracture healingP M Huddleston, J M Steckelberg, A D Hanssen, et al.
Journal of Clinical Microbiology|November 4, 2000
Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experienceR Patel, K E Piper, M S Rouse, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditisM S Rouse, J M Steckelberg, C M Brandt, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditisC M Brandt, M S Rouse, B M Tallan, et al.
The Journal of Infectious Diseases|April 1, 1996
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agentsC M Brandt, M S Rouse, N W Laue, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococciW C Hellinger, M S Rouse, P M Rabadan, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditisJ M Steckelberg, M S Rouse, B M Tallan, et al.
The Journal of Infectious Diseases|December 23, 1999
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitisR Patel, M S Rouse, M V Florez, et al.
Tissue Antigens|December 19, 2007
Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic miceG Rajagopalan, G Polich, M M Sen, et al.
Journal of Clinical Microbiology|October 17, 1998
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolatesR Patel, K E Piper, M S Rouse, et al.
Pageof 3